July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

July 02, 2025

Medical Oddities: Leprosy’s Old New World Secret

This week’s clinical grab bag: tea for gloom, ancient leprosy, smoggy fibrosis & power peeing.

Conexiant

July 02, 2025

Gel Offers Relief for Axillary Sweating 

A pooled analysis of two phase 3 trials found that a once-daily topical anticholinergic gel significantly improved sweat reduction and symptom severity in patients with axillary hyperhidrosis, with a tolerable safety profile.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Herbal Emollient Shows Lasting Relief for Eczema

Clinical trial finds herbal emollients with ginger and cannabidiol reduce itch, improve symptoms, and restore skin barrier in mild atopic dermatitis.

Conexiant

June 18, 2025

Is Pediatric Vitiligo Associated With Hearing, Retinal Risks?

Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.

Conexiant

June 12, 2025

What’s Behind TikTok’s Skin Craze?

Study finds pediatric regimens cost $168 on average and include potential irritants.

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

November 27, 2024

Processed Foods Linked to Active Psoriasis: Study

French researchers in JAMA Dermatology linked high ultraprocessed food consumption to increased rates of psoriasis, emphasizing the need for further investigation.

Conexiant